CT-based Hounsfield unit values reflect the degree of steatohepatitis in patients with low-grade fatty liver disease
- PMID: 36932382
- PMCID: PMC10022198
- DOI: 10.1186/s12876-023-02717-3
CT-based Hounsfield unit values reflect the degree of steatohepatitis in patients with low-grade fatty liver disease
Abstract
Background/aims: Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. Ultrasound, the most used tool for diagnosing NAFLD, is operator-dependent and shows suboptimal performance in patients with mild steatosis. However, few studies have been conducted on whether alternative noninvasive methods are useful for diagnosing mild hepatic steatosis. Also, little is known about whether noninvasive tests are useful for grading the severity of hepatic steatosis or the degree of intrahepatic inflammation. Therefore, we aimed to evaluate whether the HSI, the FLI and HU values in CT could be used to discriminate mild hepatic steatosis and to evaluate the severity of hepatic steatosis or the degree of intrahepatic inflammation in patients with low-grade fatty liver disease using liver biopsy as a reference standard.
Methods: Demographic, laboratory, CT imaging, and histological data of patients who underwent liver resection or biopsy were analyzed. The performance of the HSI, HU values and the FLI for diagnosing mild hepatic steatosis was evaluated by calculating the area under the receiver operating characteristic curve. Whether the degree of hepatic steatosis and intrahepatic inflammation could be predicted using the HSI, HU values or the FLI was also analyzed. Moreover, we validate the results using magnetic resonance imaging proton density fat fraction as an another reference standard.
Results: The AUROC for diagnosing mild hepatic steatosis was 0.810 (p < 0.001) for the HSI, 0.732 (p < 0.001) for liver HU value, 0.802 (p < 0.001) for the difference between liver and spleen HU value (L-S HU value) and 0.813 (p < 0.001) for the FLI. Liver HU and L-S HU values were negatively correlated with the percentage of hepatic steatosis and NAFLD activity score (NAS) and significantly different between steatosis grades and between NAS grades. The L-S HU value was demonstrated the good performance for grading the severity of hepatic steatosis and the degree of intrahepatic inflammation.
Conclusions: The HU values on CT are feasible for stratifying hepatic fat content and evaluating the degree of intrahepatic inflammation, and the HSI and the FLI demonstrated good performance with high sensitivity and specificity in diagnosing mild hepatic steatosis.
Keywords: Hepatic steatosis; Hounsfield unit; Liver biopsy; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures





Similar articles
-
Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates.JHEP Rep. 2021 Sep 30;3(6):100381. doi: 10.1016/j.jhepr.2021.100381. eCollection 2021 Dec. JHEP Rep. 2021. PMID: 34786549 Free PMC article.
-
Hepatic Alanine Differentiates Nonalcoholic Steatohepatitis From Simple Steatosis in Humans and Mice: A Proton MR Spectroscopy Study With Long Echo Time.J Magn Reson Imaging. 2017 Nov;46(5):1298-1310. doi: 10.1002/jmri.25673. Epub 2017 Feb 22. J Magn Reson Imaging. 2017. PMID: 28225569
-
Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes.J Gastroenterol Hepatol. 2018 Jan;33(1):270-276. doi: 10.1111/jgh.13814. J Gastroenterol Hepatol. 2018. PMID: 28464337
-
Radiologic evaluation of nonalcoholic fatty liver disease.World J Gastroenterol. 2014 Jun 21;20(23):7392-402. doi: 10.3748/wjg.v20.i23.7392. World J Gastroenterol. 2014. PMID: 24966609 Free PMC article. Review.
-
Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis.Eur Radiol. 2019 Jul;29(7):3564-3573. doi: 10.1007/s00330-019-06072-4. Epub 2019 Mar 21. Eur Radiol. 2019. PMID: 30899974 Review.
Cited by
-
Association between non-alcoholic fatty liver disease and the risk of pulmonary nodules in patients with intestinal polyps.J Thorac Dis. 2024 Jun 30;16(6):3990-3999. doi: 10.21037/jtd-24-754. Epub 2024 Jun 28. J Thorac Dis. 2024. PMID: 38983169 Free PMC article.
-
The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review.Diagnostics (Basel). 2023 Oct 26;13(21):3316. doi: 10.3390/diagnostics13213316. Diagnostics (Basel). 2023. PMID: 37958212 Free PMC article. Review.
-
Accuracy of Non-Invasive Imaging Techniques for the Diagnosis of MASH in Patients With MASLD: A Systematic Review.Liver Int. 2025 Apr;45(4):e16127. doi: 10.1111/liv.16127. Epub 2024 Oct 14. Liver Int. 2025. PMID: 39400428 Free PMC article.
-
Non-linear relationship between the hepatic steatosis index and glycemic progression: evidence from a large-scale retrospective cohort study in a Chinese population.BMC Gastroenterol. 2025 Jul 1;25(1):484. doi: 10.1186/s12876-025-04068-7. BMC Gastroenterol. 2025. PMID: 40597738 Free PMC article.
-
Association between hepatic steatosis index and glucose status conversion from impaired fasting glucose base on Chinese adults: a cohort study from real-world.Eur J Med Res. 2025 Feb 14;30(1):100. doi: 10.1186/s40001-025-02354-4. Eur J Med Res. 2025. PMID: 39953638 Free PMC article.
References
-
- Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328–357. doi: 10.1002/hep.29367. - DOI - PubMed
-
- Williams VF, Taubman SB, Stahlman S. Non-alcoholic fatty liver disease (NAFLD), active component, U.S. Armed Forces, 2000–2017. Msmr. 2019;26(1):2–11. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical